Exchange: OTC·Updated 02:59 PM EDT

NMTRQ 9 Meters Biopharma Inc

$0.00
$0.00
(0.00%)
Today
Reported EarningsMay 23
Mkt Cap$14.00
Vol65.00

About NMTRQ

9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.
58

Bullish Sentiment

How do you feel about NMTRQ?

Advertisement|Remove ads.